Oppenheimer Asset Management Inc. Charles River Laboratories International, Inc. Transaction History
Oppenheimer Asset Management Inc.
- $7.78 Billion
- Q1 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 37,576 shares of CRL stock, worth $5.31 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
37,576
Previous 32,905
14.2%
Holding current value
$5.31 Million
Previous $6.07 Million
6.9%
% of portfolio
0.07%
Previous 0.08%
Shares
30 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$862 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$718 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$605 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$338 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$275 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.18B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...